Mark Fletcher serves as Executive at GENEREX BIOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, Mark Fletcher has executed 14 insider transactions totaling $290.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 16, 2016 involved exercising options for 4,447,111 shares valued at $0.
Mark Fletcher currently holds 15,821,836 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Fletcher has been a net seller of GNBT stock. They have purchased $27.7K and sold $262.9K worth of shares.
Mark Fletcher's most recent insider trade was on Feb 16, 2016, when they sold 4,447,111 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 14,890,033 |
| $N/A |
| Discretionary |
| Oct 6, 2014 | GNBT | $0 | Option Exercise | 470,726 | $N/A | Discretionary |
| Apr 6, 2011 | GNBT | $4.8K | Purchase | 20,000 | $0.24 | Discretionary |
| Jan 4, 2010 | GNBT | $4.5K | Purchase | 8,700 | $0.52 | Discretionary |
| Nov 13, 2009 | GNBT | $4.9K | Purchase | 10,000 | $0.49 | Discretionary |
| Jan 12, 2009 | GNBT | $3.3K | Purchase | 10,159 | $0.32 | Discretionary |
| Jan 12, 2009 | GNBT | $726 | Purchase | 2,200 | $0.33 | Discretionary |
| Oct 31, 2008 | GNBT | $9.3K | Purchase | 24,500 | $0.38 | Discretionary |
| Oct 31, 2008 | GNBT | $185 | Purchase | 500 | $0.37 | Discretionary |
| Apr 18, 2008 | GNBT | $148.9K | Sale | 128,342 | $1.16 | Discretionary |
| Apr 18, 2008 | GNBT | $222.5K | Option Exercise | 250,000 | $0.89 | Discretionary |
| Apr 18, 2008 | GNBT | $114.0K | Sale | 100,000 | $1.14 | Discretionary |
| Aug 17, 2007 | GNBT | $0 | Award | 175,000 | $N/A | Discretionary |